Published at the weekend, the 21st annual Sunday Times Virgin Fast Track 10 league table identified some of the UK’s most disruptive private companies. The 10 companies are recognised for having a business model, product or service that is creating a new market, or transforming existing markets and rapidly taking market share from competitors.
The list includes companies from a variety of sectors all driven by their innovative thinking, investment in technology and finding new solutions to old problems.
CMR has developed Versius, a surgical robot designed to meet the complex requirements of laparoscopic surgery and has filed more than 100 patents throughout its development. Versius, inspired by the human arm, has remarkable dexterity, flexibility and reach, to enable a new paradigm in surgical experience and to help CMR achieve its aim of making minimal access surgery available to all.
The award is further testament to a company with a significant growth rate. CMR has more than doubled in size in the last year. It now employs more than 140 people in Cambridge, and expects to grow significantly in 2018.
Martin Frost, CMR’s Chief Executive Officer said, “As a company located in Cambridge, Europe’s innovation capital, we are only too aware of the scale of innovation happening in the UK. To be named as a top 10 UK disruptor is truly an honour. This award is testament to the dedication of our hard-working high-skilled team determined to revolutionise surgery with the launch of our next-generation robot.”
Peter Kelly, Managing Director, Virgin Media Business, said: “We are delighted to name CMR as a one of the UK’s most disruptive businesses. They have seen an opportunity and made it their purpose to disrupt long established markets and practices.
“For us at Virgin Media Business it is our purpose to help all businesses fulfil their digital potential and we recognise how much digital advancement has been a key focus for these new and disruptive companies.”
CMR is invited to attend the 21st annual Fast Track 100 conference and awards dinner, which will be held on Wednesday 23 May 2018 in London. The event is co-hosted by Sir Richard Branson.
About CMR Surgical Limited
CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit: www.cmrsurgical.com
About the CMR surgical robotic system
Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily in the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort. Intended to be used across a range of surgical specialties, the versatility and portability of Versius – enabled by a unique and patented four-axis wrist joint – expands the potential for higher utilisation. This allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.
1 Industry Forecast, Accuray Research